Cervicogenic Headache, Cognitive Dysfunction
Frequency of Cognitive Dysfunction in Individuals With Cervicogenic Headache
1 other identifier
observational
60
1 country
1
Brief Summary
The goal of this study was to determine the frequency of cognitive dysfunction in patients with cervicogenic headache. participants will be asked questions to determine their cognitive status at once.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
October 5, 2022
CompletedFirst Posted
Study publicly available on registry
October 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2023
CompletedOctober 26, 2022
October 1, 2022
11 months
October 5, 2022
October 25, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
cognitive status
01.12.2022
Study Arms (2)
patients with cervicogenic headache
visual pain scale Beck depression scale Pain catastrophizing scale Short Form-36 Standard Mini mental test Montreal cognitive assessment scale
healthy controls
visual pain scale Beck depression scale Pain catastrophizing scale Short Form-36 Standard Mini mental test Montreal cognitive assessment scale
Interventions
evaluation of pain, fatigue, mood, quality of life, cognitive status
Eligibility Criteria
30 patients with cervicogenic headache and 30 healthy volunteers
You may qualify if:
- Clinical Diagnosis of cervicogenic headache be over 18
You may not qualify if:
- those under the age of 18 Those with neurological deficits Those with rheumatic diseases such as fibromyalgia, polymyalgia rheumatica, ankylosing spondylitis, rheumatoid arthritis Surgery in the cervical region in the past 6 months Those with widespread pain, significant pain in another anatomical location (eg, gonarthrosis) Those who use drugs or substances (alcohol, drugs, etc.) that may cause cognitive impairment Those with known neurological diseases such as cerebrovascular disease, MS, Parkinson's, dementia Those with major psychiatric illness Those with communication problems Those who have started psychiatric medical treatment in the last three months Those with significant hearing or vision problems Those with a history of uncontrollable systemic disease (cardiovascular, pulmonary, hepatic, renal, hematological, endocrine..)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Konya Beyhekim Research and Training Hospital
Konya, Selçuklu, 42060, Turkey (Türkiye)
Related Publications (2)
Bogduk N, Govind J. Cervicogenic headache: an assessment of the evidence on clinical diagnosis, invasive tests, and treatment. Lancet Neurol. 2009 Oct;8(10):959-68. doi: 10.1016/S1474-4422(09)70209-1.
PMID: 19747657BACKGROUNDSjaastad O. Cervicogenic headache: comparison with migraine without aura; Vaga study. Cephalalgia. 2008 Jul;28 Suppl 1:18-20. doi: 10.1111/j.1468-2982.2008.01610.x.
PMID: 18494988BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical doctor
Study Record Dates
First Submitted
October 5, 2022
First Posted
October 7, 2022
Study Start
January 1, 2022
Primary Completion
December 1, 2022
Study Completion
January 1, 2023
Last Updated
October 26, 2022
Record last verified: 2022-10